Continuous Glucose Monitoring (CGM) in Kidney-Transplanted Adults
Sponsor: University of Alabama at Birmingham
Terminated
cessation of funds for study activities
Other terminated trials from University of Alabama at Birmingham
- Anal Incontinence · Phase PHASE4 · Feb 2026
- Respiratory Depression · May 2025
- Anaplastic Astrocytoma of Brain · Phase PHASE1 · Mar 2025
- Adult Cardiac Surgery · Nov 2024
- Contact Lens Complication · Phase PHASE4 · Aug 2024
See all terminations from University of Alabama at Birmingham
Other Diabetes Mellitus trials with similar outcome
Listed as NCT05352230, this NA trial focuses on Diabetes Mellitus and Kidney Transplant; Complications and remains terminated or withdrawn. Sponsored by University of Alabama at Birmingham, it has been updated 11 times since 2023, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jun 2024 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated · Phase: PHASE1 → NA
-
Jun 2023 — Jun 2024 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
▶ Show 6 earlier versions
-
May 2023 — Jun 2023 [monthly]
Not Yet Recruiting PHASE1
-
Mar 2023 — May 2023 [monthly]
Not Yet Recruiting PHASE1
-
Dec 2022 — Mar 2023 [monthly]
Not Yet Recruiting PHASE1
-
Sep 2022 — Dec 2022 [monthly]
Not Yet Recruiting PHASE1
-
Jun 2022 — Sep 2022 [monthly]
Not Yet Recruiting PHASE1
-
May 2022 — Jun 2022 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Alabama at Birmingham
For direct contact, visit the study record on ClinicalTrials.gov .